 |
Sitaxsentan Sodium |
|---|---|
| Trade Name | |
| Orphan Indication | Pulmonary Arterial Hypertension |
| USA Market Approval | USA |
| USA Designation Date | 2004-11-02 00:00:00 |
| Sponsor | Pfizer Global Research and Development;50 Pequot Avenue 6025-B4137;New London, Connecticut, 06320 |
